Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Exploring Bolt (BOLT) stock? View BOLT's stock price, price target, dividend, earnings, financials, forecast, insider trades, and SEC filings at. Based on short-term price targets offered by three analysts, the average price target for Bolt Biotherapeutics, Inc. comes to $ The forecasts range from a. Based on the our new experimental Bolt price prediction simulation, BOLT's value in expected to grow by %% to $ if the best happened. The. Bolt Biotherapeutics Forecast Revenue Growth Analysts estimate an earnings increase this quarter of $ per share, a decrease next quarter of $ per.
Forge Price™ is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints. Research Bolt Biotherapeutics' (Nasdaq:BOLT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. The Bolt Biotherapeutics, Inc. stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week. Explore BOLT - Bolt Biotherapeutics Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to Free Bolt Projects (BSLK) analysis tools, including analyst ratings and target price forecasts, help you make informed investment decisions. According to WalletInvestor, in Bolt Token investors should expect price growth to $, which seems a good reason to consider Bolt Token as an. On average, Wall Street analysts predict that Bolt Biotherapeutics's share price could reach $ by May 15, The average Bolt Biotherapeutics stock price. According to our Bolt Biotherapeutics, Inc. stock prediction for , BOLT stock will be priced at $ in This forecast is based on the stock's. Next quarter's sales forecast for BOLT is $M with a range of $K to $M. The previous quarter's sales results were $M. BOLT beat its sales. According to analysts, BOLT price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. BOLT PROJECTS HOLDINGS INC C/WTS EXP 31/07/ (TO PUR COM) Stock Analyst Ratings & Price Target. Analyst Rating. No Data. Price Target. No Data. Review BOLT.
Bolt Metals (PCRCF) stock price prediction is USD. The Bolt Metals stock forecast is USD for June 28, Saturday;. View Bolt Biotherapeutics, Inc. BOLT stock quote prices, financial information, real-time forecasts, and company news from CNN. The average target predicts an increase of % from the current stock price of Stock Quote & Chart · Analyst Coverage · Corporate Governance · Governance forecasts or predictions of Bolt Biotherapeutics or its management. Bolt. Find the latest Bolt Biotherapeutics, Inc. (BOLT) stock quote, history, news and other vital information to help you with your stock trading and investing. BOLT on Base(BOLT) price forecast up to $ based on halving and market trends. Real-time price update | Get detailed analytics for BOLT on Base price. According to our current Bolt price prediction, the price of Bolt is predicted to drop by % and reach $ by September 30, Per our technical. Bolt Biotherapeutics (BOLT) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bolt Biotherapeutics Stock Forecast, BOLT stock price prediction. Price target in 14 days: USD. The best long-term & short-term Bolt Biotherapeutics.
Bolt Threads stock price; Available deals in Bolt Threads and all other companies; Deal offering documents; EquityZen's proprietary data and insights, including. Bolt Biotherapeutics, Inc. holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days. Specialty Bolt & Screw (SBS) faced challenges with excessive inventory and low forecast accuracy. The stock levels and item classifications, improving. Price Target. No data available. Stock Upgrades/Downgrades. This card shows analyst upgrades/downgrades for Bolt Projects Holdings, Inc.. An analyst rating is. Bolt has raised $B over 16 rounds. Bolt's latest funding round was a Line of Credit for $M on May 3, Bolt's valuation in January was $8,M.
BOLT Stock Overview · Revenue is forecast to grow % per year · Currently unprofitable and not forecast to become profitable over the next 3 years · Does. BOLT Forecast, Long-Term Price Predictions for Next Months and Year: , BOLT prediction details. BOLT (BOLT) stock price forecast, prediction, BOLT. In their Bolt Token price predictions for , runninwideopen.site's forecasts the coin's price to go above $ by December. Forecasting Bolt Token's. The price of Bolt (BOLT) is calculated in real-time by aggregating the latest data across 4 exchanges and 5 markets, using a global volume-weighted average. Bolt Biotherapeutics Inc Stock (BOLT) is expected to reach an average price of $ in , with a high prediction of $ and a low estimate of $ BOLT BIOTHERAPEUTICS INC (BOLT) Price Targets From Analysts ; , 4, $8, $3, $ ; , 4, $8, $, $ Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Bolt price is correlated with the top 10 coins by market cap with a price of price predictions to try and get an edge over the competition. Some. Based on the our new experimental Bolt price prediction simulation, BOLT's value in expected to grow by %% to $ if the best happened. The. View Bolt Biotherapeutics, Inc. BOLT stock quote prices, financial information, real-time forecasts, and company news from CNN. Trade Bolt Biotherapeutics, Inc. - BOLT CFD ; Prev. Close, ; Open, ; 1-Year Change, % ; Day's Range, - The average stock forecast for Bolt Metals Corp (runninwideopen.site) is - CAD. This price target corresponds to an upside of %. The range of stock forecasts for. Bolt Biotherapeutics (BOLT) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Bolt has raised $B over 16 rounds. Bolt's latest funding round was a Line of Credit for $M on May 3, Bolt's valuation in January was $8,M. Bolt Metals (PCRCF) stock price prediction is USD. The Bolt Metals stock forecast is USD for June 28, Saturday;. BOLT is trading in the range of $ - $ in the past 30 days. Doji Candlestick Pattern - stock is forming a Doji which is a reversal pattern. If a Doji. Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BOLT is experiencing. BOLT on Base(BOLT) price forecast up to $ based on halving and market trends. Real-time price update | Get detailed analytics for BOLT on Base price. Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. Stock Quote & Chart · Analyst Coverage · Corporate Governance · Governance forecasts or predictions of Bolt Biotherapeutics or its management. Bolt. Currently, Wall Street analysts rate BOLT as Neutral on average. Additionally, the current consensus price target from analysts is $ To see all of BOLT's. Track Bolt Biotherapeutics Inc (BOLT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Bolt Biotherapeutics Stock Forecast, BOLT stock price prediction. Price target in 14 days: USD. The best long-term & short-term Bolt Biotherapeutics. For the fiscal year ending Dec , the consensus EPS* forecast has remained the same over the past week at and decreased over the past month from According to analysts, BOLT price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Price-To-Sales vs Industry: BOLT is good value based on its Price-To-Sales Ratio (x) compared to the US Biotechs industry average (x). Bolt has raised $B over 16 rounds. Bolt's latest funding round was a Line of Credit for $M on May 3, Bolt's valuation in January was $8,M. Find the latest Bolt Biotherapeutics, Inc. (BOLT) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, Wall Street analysts predict that Bolt Biotherapeutics's share price could reach $ by May 15, The average Bolt Biotherapeutics stock price. Bolt Biotherapeutics, Inc. holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days.
See real-time Bolt Threads price charts, funding & market data. Connect with the world's best Bolt Threads brokers to learn how to buy Bolt Threads stock.
Home Depot Credit Card Approval Credit Score | Easy Ways To Come Up With Money